Cargando…
Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia
INTRODUCTION: Activating calcium sensing receptor (CaSR) mutations cause autosomal dominant hypocalcemia (ADH) characterized by low serum calcium, inappropriately low PTH and relative hypercalciuria. Four activating CaSR mutations cause additional renal wasting of sodium, chloride and other salts, a...
Autores principales: | Letz, Saskia, Haag, Christine, Schulze, Egbert, Frank-Raue, Karin, Raue, Friedhelm, Hofner, Benjamin, Mayr, Bernhard, Schöfl, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266668/ https://www.ncbi.nlm.nih.gov/pubmed/25506941 http://dx.doi.org/10.1371/journal.pone.0115178 |
Ejemplares similares
-
Synthesis of the calcilytic ligand NPS 2143
por: Johansson, Henrik, et al.
Publicado: (2013) -
The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Hannan, Fadil M., et al.
Publicado: (2015) -
The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca(2+) channels
por: Greenberg, Harry Z.E., et al.
Publicado: (2016) -
Calcilytic NPS2143 promotes proliferation and inhibits apoptosis of spontaneously hypertensive rat vascular smooth muscle cells via activation of the renin-angiotensin system
por: Zhao, Yongli, et al.
Publicado: (2020) -
Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143—Further Implications for Alzheimer's Therapy
por: Chiarini, Anna, et al.
Publicado: (2017)